NLRP3 and metabolic dysfunction-associated steatohepatitis: In addition, MCs can also induce NLRP3-mediated inflammatory responses in liver cells, which will increase the expression of IL-1β in cells and promote the progression of non-alcoholic steatohepatitis [68].